Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01519 |
| Species: | Homo sapiens |
| Position : | chr9:21016991-21017491 |
| Year: | 2020 |
| Title: | A genetic variant controls interferon-?? gene expression in human myeloid cells by preventing C/EBP-?? binding on a conserved enhancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 33147212 |
| MONDO: | |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Primary monocyte-derived macrophages |
| CVCL ID: | |
| Cell Type: | macrophage |
| Cell Ontology ID: | CL:0000235 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | Hi-C, ChIP-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | IFNB1 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|